IMCRImmunocore Holdings plc
What is the market doing?
No clear lean: nothing decisive, though heavily shorted (+15% of shares).
Rangebound, no clear trend. Oversold (RSI 22). Price is −9% vs its 200-day average.
Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How IMCR is trading
Immunocore Holdings plc is −9.8% over the past year while the S&P 500 is +18%: 28 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −8.9%
vs 200-day average · below trend, but not far
- RSI (14)
- 22
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 27%
Below its 52-week high
Details›
- Last close2026-10-09
- $29.39
- 1 monthS&P 500 +2.7%
- −13%
- 1 yearS&P 500 +18%
- −9.8%
- 5 yearsS&P 500 +88%
- −8.2%
- vs 50-day average$33.44
- −12%
- 52-week high
- $40.22
- 52-week low
- $27.79
- Annualised volatility
- 40%
| Year | Return |
|---|---|
| 2026 (year to date) | −15% |
| 2025 | +18% |
| 2024 | −57% |
| 2023 | +20% |
| 2022 | +67% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 3 of 5 | −3.1% |
| Feb | 5 | 0 of 5 | −6.2% |
| Mar | 6 | 2 of 6 | +0.75% |
| Apr | 6 | 3 of 6 | +1.0% |
| May | 6 | 3 of 6 | −1.4% |
| Jun | 6 | 3 of 6 | −0.64% |
| Jul | 6 | 5 of 6 | +8.1% |
| Aug | 6 | 3 of 6 | +0.43% |
| Sep | 6 | 2 of 6 | −4.8% |
| Oct | 6 | 2 of 6 | −0.25% |
| Nov | 5 | 4 of 5 | +9.5% |
| Dec | 5 | 1 of 5 | −1.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.